We have recently shown therapeutic efficacy of combined cidofovir (a viral DNA polymerase inhibitor) and etanercept or STAT3 inhibitor treatment in ameliorating lung pathology and protecting mice from lethal OPXV pneumonia [36]. The gene discussed is STAT3; the disease is susceptibility to pneumonia measurement.